Testing effectiveness (Phase 2)Ended earlyNCT02947022
What this trial is testing
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Who this might be right for
HeadacheCognitive DisturbanceSkin Hyperpigmentation+1 more
University of North Carolina, Chapel Hill 1